ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
ProPhase Labs's revenue for the twelve months ending Jun 30, 2026 was $3.85M, down 31.2% year over year. For fiscal 2025 it was $4.35M, down 35.8% from the year before. Over ten years it grew 5.6% a year on average. The highest annual figure on record is $122.65M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.35M | -35.8% |
| FY2024 | Dec 31, 2024 | $6.77M | -80.6% |
| FY2023 | Dec 31, 2023 | $34.98M | -71.5% |
| FY2022 | Dec 31, 2022 | $122.65M | +55.2% |
| FY2021 | Dec 31, 2021 | $79.04M | +444.6% |
| FY2020 | Dec 31, 2020 | $14.51M | +47.0% |
| FY2019 | Dec 31, 2019 | $9.88M | -24.8% |
| FY2018 | Dec 31, 2018 | $13.13M | +33.0% |
| FY2017 | Dec 31, 2017 | $9.87M | +134.6% |
| FY2016 | Dec 31, 2016 | $4.21M | +67.0% |
| FY2015 | Dec 31, 2015 | $2.52M | -88.6% |
| FY2014 | Dec 31, 2014 | $22.07M | -11.8% |
| FY2013 | Dec 31, 2013 | $25.03M | +11.7% |
| FY2012 | Dec 31, 2012 | $22.41M | +28.4% |
| FY2011 | Dec 31, 2011 | $17.45M | +20.3% |
| FY2010 | Dec 31, 2010 | $14.50M | -26.8% |
| FY2009 | Dec 31, 2009 | $19.82M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.01M | -18.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.17M | -18.3% |
| Q4 FY2025 | Dec 31, 2025 | $784.00K | -47.5% |
| Q3 FY2025 | Sep 30, 2025 | $883.00K | -37.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.25M | -17.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.43M | -39.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.49M | -57.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.42M | -83.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.50M | -88.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.36M | -87.8% |
| Q4 FY2023 | Dec 31, 2023 | $3.50M | -84.0% |
| Q3 FY2023 | Sep 30, 2023 | $8.37M | -65.4% |
| Q2 FY2023 | Jun 30, 2023 | $13.22M | -54.6% |
| Q1 FY2023 | Mar 31, 2023 | $19.30M | -59.4% |
| Q4 FY2022 | Dec 31, 2022 | $21.82M | -51.7% |
| Q3 FY2022 | Sep 30, 2022 | $24.20M | +154.7% |
| Q2 FY2022 | Jun 30, 2022 | $29.09M | +219.7% |
| Q1 FY2022 | Mar 31, 2022 | $47.53M | +210.7% |
| Q4 FY2021 | Dec 31, 2021 | $45.14M | +774.3% |
| Q3 FY2021 | Sep 30, 2021 | $9.50M | +147.4% |
| Q2 FY2021 | Jun 30, 2021 | $9.10M | +151.2% |
| Q1 FY2021 | Mar 31, 2021 | $15.30M | +710.4% |
| Q4 FY2020 | Dec 31, 2020 | $5.16M | +64.4% |
| Q3 FY2020 | Sep 30, 2020 | $3.84M | +38.8% |
| Q2 FY2020 | Jun 30, 2020 | $3.62M | +119.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.89M | -18.6% |
| Q4 FY2019 | Dec 31, 2019 | $3.14M | -23.3% |
| Q3 FY2019 | Sep 30, 2019 | $2.77M | +13.4% |
| Q2 FY2019 | Jun 30, 2019 | $1.65M | -48.2% |
| Q1 FY2019 | Mar 31, 2019 | $2.32M | -32.0% |
| Q4 FY2018 | Dec 31, 2018 | $4.09M | -1.4% |
| Q3 FY2018 | Sep 30, 2018 | $2.44M | -19.8% |
| Q2 FY2018 | Jun 30, 2018 | $3.19M | +67.2% |
| Q1 FY2018 | Mar 31, 2018 | $3.41M | +341.9% |
| Q4 FY2017 | Dec 31, 2017 | $4.15M | +441.2% |
| Q3 FY2017 | Sep 30, 2017 | $3.04M | +116.8% |
| Q2 FY2017 | Jun 30, 2017 | $1.91M | – |
| Q1 FY2017 | Mar 31, 2017 | $771.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $767.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $1.40M | – |
See a number that looks wrong?